A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRS
Condition: Infections, Bacterial Intervention: Drug: Augmentin ES Sponsor: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2022 Category: Research Source Type: clinical trials
Beta-Lactam Containing Regimen for the Shortening of Buruli Ulcer Disease Therapy
Condition: Buruli Ulcer Interventions: Drug: Standard [RC8]: rifampicin plus clarithromycin (RC) therapy for 8 weeks.; Drug: Investigational [RCA4]: standard (RC) plus amoxicillin/clavulanate (A) for 4 weeks. Sponsors: Fundacion Agencia Aragonesa para la Investigacion y Desarrollo (ARAID); Universidad de Zaragoza; Fondation Raoul Follereau; Université d'Abomey-Calavi; Instituto de Salud Carlos III; Fundación Anesvad Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2021 Category: Research Source Type: clinical trials